Moleculin Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.31

+0.40 (+10.23%)

As of Feb 8, 2:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +490.0% upside

Low Target $14.54

Average Target $25.43

High Target $32.33

Current Price $4.31

Current
$4.31

Target
$25.43

$14.54 $25.43 avg $32.33

Scenario Analysis

Bear Case

$14.54

237.4%

Low target

Base Case

$25.43

+490.0%

Avg target

Bull Case

$32.33

+650.1%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$26.99

-84.0% from high

52-Week Low

$11.29

+-61.8% from low

Target vs 52W High

$25.43

-5.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%